FirsthandHealth
medRxiv PreprintsInternational18 November 2026

Prospective multi-omic profiling identifies predictive and genetically supported molecular determinants of incident epilepsy

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Abstract Epilepsy affects approximately 50 million people worldwide, yet biomarkers capable of identifying individuals at risk before clinical onset are lacking, and the molecular mechanisms preceding disease onset remain poorly understood. Here, we integrated plasma proteomic, metabolomic, and genomic data from the UK Biobank to characterize molecular changes preceding epilepsy and evaluate their predictive and causal relevance. We quantified 2,923 plasma proteins in 53,000 participants and followed incident epilepsy for up to 15 years before epilepsy diagnosis. Cox proportional hazards analy
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.